Related Experiment Video
Updated: Mar 1, 2026
A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
Published on: September 9, 2015
The Impact of Pediatric-Specific Vancomycin Dosing Guidelines: A Quality Improvement Initiative
Molly Miloslavsky1,2, Marjorie F Galler1, Iman Moawad3
1Departments of Pediatrics.
Insights
A quality improvement intervention using higher initial vancomycin doses significantly improved adherence to pediatric dosing guidelines. This enhanced vancomycin therapy achieved target troughs faster with no increase in toxicity.
Area of Science:
- Pediatric Infectious Diseases
- Pharmacology
- Quality Improvement in Healthcare
Background:
- Limited data exist for pediatric vancomycin dosing to meet national guideline trough targets.
- Current practices often fail to achieve desired vancomycin trough concentrations in children.
Purpose of the Study:
- To enhance adherence to national vancomycin trough guidelines in pediatric patients.
- To evaluate the impact of a quality improvement intervention on vancomycin dosing and therapeutic outcomes.
Main Methods:
- A quality improvement initiative implemented a standardized vancomycin dosing algorithm (15-20 mg/kg/dose q6h) based on infection severity.
- Retrospective analysis assessed baseline performance, followed by prospective evaluation of intervention impact.
- Key outcome measures included initial therapeutic vancomycin trough achievement and time to reach therapeutic levels.
Main Results:
- Post-intervention, the percentage of patients achieving an initial therapeutic trough increased significantly (6.1% to 20.9%, P=.03).
- The proportion of patients with troughs between 10-20 µg/mL rose from 8.2% to 40.3% (P<.001).
- Time to therapeutic trough decreased from 2.78 to 1.56 days (P=.001), with no significant change in vancomycin-related toxicity.
Conclusions:
- Quality improvement methodology and standardized higher initial vancomycin doses effectively improved adherence to pediatric trough guidelines.
- The intervention demonstrated improved vancomycin therapeutic targeting without compromising patient safety.
Background And Objectives:
There are limited data guiding vancomycin dosing practices in the pediatric population to target the goal troughs recommended by national vancomycin guidelines. In this study, we sought to improve adherence to guideline trough targets through a quality improvement intervention.
Methods:
A retrospective analysis was first conducted to assess baseline performance. A multidisciplinary team then developed and implemented a standardized dosing algorithm recommending 15 mg/kg per dose for mild and moderate infections (goal trough: 10-15 µg/mL) and 20 mg/kg per dose for severe infections (goal trough: 15-20 µg/mL), both delivered every 6 hours (maximum single dose: 750 mg). The impact of the intervention was evaluated prospectively using standard statistics and quality improvement methodology. The outcome measures included the percentage of patients with an initial therapeutic trough and the time to therapeutic trough.
Results:
A total of 116 patients (49 preintervention, 67 postintervention) were included. Postintervention, there was a significant increase in the percentage of patients with an initial therapeutic trough (6.1% to 20.9%, P = .03) and in the percentage of patients with initial troughs between 10 and 20 µg/mL (8.2% to 40.3%, P < .001). The time to therapeutic trough decreased from 2.78 to 1.56 days (P = .001), with the process control chart showing improved control postintervention. Vancomycin-related toxicity was unchanged by the intervention (6.1% versus 4.5%; P = .70).
Conclusions:
Using quality improvement methodology with standardized higher initial vancomycin doses, we demonstrated improved adherence to national trough guidelines without noted safety detriment.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
01:29Drug Dosing: Infants and Children
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations